What supplements are recommended for patients taking phenytoin (Dilantin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Supplements for Patients Taking Phenytoin

Patients taking phenytoin (Dilantin) should receive vitamin D and calcium supplementation to prevent bone mineral density loss and hypocalcemia, and should avoid vitamin A supplementation due to risk of toxicity.

Key Supplements to Consider

Recommended Supplements:

  1. Vitamin D

    • Essential due to phenytoin's effect on vitamin D metabolism
    • Phenytoin accelerates vitamin D catabolism, leading to decreased 25-hydroxycholecalciferol levels 1
    • Aim for 25-OH vitamin D levels >20 ng/ml (50 mmol/l) 2
    • May require higher doses than standard supplementation
  2. Calcium

    • Critical to prevent phenytoin-induced hypocalcemia
    • Patients should meet age-related recommended dietary allowance for calcium 2
    • Low calcium levels can worsen seizure control 3
    • Dietary evaluation recommended to ensure adequate intake

Monitoring Requirements:

  • Regular monitoring of serum calcium, vitamin D, and alkaline phosphatase levels
  • Consider bone mineral density testing for long-term phenytoin users
  • Monitor for signs of hypocalcemia (muscle cramps, paresthesias, seizures)

Supplements to Avoid or Use with Caution

  1. Vitamin A

    • Avoid supplementation beyond recommended dietary allowance
    • Simultaneous use with phenytoin can increase risk of hypervitaminosis A 2
  2. Folic Acid

    • Consider supplementation as phenytoin may decrease folate levels
    • May help prevent megaloblastic anemia

Mechanism of Phenytoin's Effects on Bone and Vitamin Metabolism

Phenytoin affects bone health through multiple mechanisms:

  • Accelerates vitamin D metabolism, reducing 25-hydroxycholecalciferol levels 1
  • Directly inhibits osteoblast proliferation at therapeutic concentrations 4
  • Increases bone turnover markers like pyridinoline crosslinks 4
  • May cause secondary hyperparathyroidism in some patients 5

Clinical Implications

  • Long-term phenytoin use is associated with significantly lower bone mineral density, particularly in the lumbar spine 4
  • Risk increases with duration of therapy
  • Hypocalcemia can be resistant to correction until phenytoin is discontinued 3
  • In rare cases, severe vitamin D deficiency and hypocalcemia can lead to loss of seizure control 3

Practical Recommendations

  • Initiate vitamin D and calcium supplementation at the start of phenytoin therapy
  • Monitor calcium and vitamin D levels every 3-6 months
  • Consider switching to alternative anticonvulsants like levetiracetam in patients who develop significant bone metabolism issues 5
  • Avoid alcohol consumption during phenytoin therapy as it can increase metabolism to potentially toxic metabolites 2

Drug Interactions to Consider

  • Phenytoin may reduce protein binding of other medications
  • Phenytoin reduces the contraceptive effect of progestin-only pills (mini-pill) 2
  • Avoid concomitant use with tetracyclines due to risk of increased intracranial pressure 2

By ensuring proper supplementation with vitamin D and calcium, monitoring bone health regularly, and avoiding contraindicated supplements, the adverse effects of phenytoin on bone metabolism can be minimized while maintaining effective seizure control.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Long-term anticonvulsant therapy leads to low bone mineral density--evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2000

Research

Phenytoin Induced Osteopathy -Too Common to be Neglected.

Journal of clinical and diagnostic research : JCDR, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.